Dyne Therapeutics Q1 Net Loss Widens
(RTTNews) - Dyne Therapeutics, Inc. (DYN) reported Monday that net loss for the first quarter was $120.85 million or $0.73 per share, compared to net loss of $115.36 million or $1.05 per share in the prior-year quarter.
In Thursday's pre-market trading, DYN is trading on the Nasdaq at $17.50, down $0.11 or 0.62 percent.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.